These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9372316)

  • 21. Decreased polymorphonuclear leucocyte chemotactic response to leukotriene B4 in cystic fibrosis.
    Lawrence RH; Sorrelli TC
    Clin Exp Immunol; 1992 Aug; 89(2):321-4. PubMed ID: 1322257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of dapsone-induced methaemoglobinaemia in the rat isolated perfused liver.
    Coleman MD; Hoaksey PE; Breckenridge AM; Park BK
    J Pharm Pharmacol; 1990 May; 42(5):302-7. PubMed ID: 1976775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A field trial among leprosy patients in Nigeria with depot injections of dapsone and monoacetyldapsone.
    Pieters FA; Woonink F; Zuidema J
    Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):10-20. PubMed ID: 3373080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic leukotriene B4 is a potent chemotaxin but a weak secretagogue for human PMN.
    Rollins TE; Zanolari B; Springer MS; Guindon Y; Zamboni R; Lau CK; Rokach J
    Prostaglandins; 1983 Feb; 25(2):281-9. PubMed ID: 6304818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methotrexate inhibits the leukotriene B4 induced intraepidermal accumulation of polymorphonuclear leukocytes.
    van de Kerkhof PC; Bauer FW; Maassen-de Grood RM
    Br J Dermatol; 1985 Sep; 113(3):251a-255a. PubMed ID: 2998429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human monocyte and polymorphonuclear leukocyte chemotactic and chemokinetic responses to leukotriene B4 and FMLP.
    Ternowitz T; Herlin T; Fogh K
    Acta Pathol Microbiol Immunol Scand C; 1987 Apr; 95(2):47-54. PubMed ID: 3037849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemolysis and Metabolic Lesion of G6PD Deficient RBCs in Response to Dapsone Hydroxylamine in a Humanized Mouse Model.
    Dziewulska KH; Reisz JA; Hay AM; D'Alessandro A; Zimring JC
    J Pharmacol Exp Ther; 2023 Sep; 386(3):323-330. PubMed ID: 37348965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of the heterogeneous membrane potential response of neutrophils to N-formyl-methionyl-leucyl-phenylalanine (FMLP) by leukotriene B4: evidence for cell recruitment.
    Fletcher MP
    J Immunol; 1986 Jun; 136(11):4213-9. PubMed ID: 3009618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of selenium deficiency on caprine polymorphonuclear leukocyte production of leukotriene B4 and its neutrophil chemotactic activity.
    Aziz E; Klesius PH
    Am J Vet Res; 1986 Feb; 47(2):426-8. PubMed ID: 3006557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of chemiluminescence in human neutrophils by dapsone.
    Webster GF; Alexander JC; McArthur WP; Leyden JJ
    Br J Dermatol; 1984 Jun; 110(6):657-63. PubMed ID: 6733037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative differences and combined effects of interleukin-8, leukotriene B4, and platelet-activating factor on neutrophil chemotaxis of the newborn.
    Tan ND; Davidson D
    Pediatr Res; 1995 Jul; 38(1):11-6. PubMed ID: 7478787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphonuclear leucocyte chemotaxis in response to leukotriene B4 in treated and untreated psoriatics.
    Green CM; Ferguson J; MacLeod TM; Millar BW; Raffle EJ
    Dermatologica; 1989; 178(1):20-2. PubMed ID: 2537239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibrin regulates neutrophil migration in response to interleukin 8, leukotriene B4, tumor necrosis factor, and formyl-methionyl-leucyl-phenylalanine.
    Loike JD; el Khoury J; Cao L; Richards CP; Rascoff H; Mandeville JT; Maxfield FR; Silverstein SC
    J Exp Med; 1995 May; 181(5):1763-72. PubMed ID: 7722453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of leukotriene B4-induced intraepidermal accumulation of polymorphonuclear leukocytes by methotrexate in psoriasis.
    Lammers AM; van de Kerkhof PC; Mier PD
    Br J Dermatol; 1987 May; 116(5):667-71. PubMed ID: 3036194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of leukotriene B5 on the accumulation of polymorphonuclear leukocytes in unstimulated and leukotriene B4-stimulated human skin.
    Wozel G; Chang A; Barth J; Happle R; van de Kerkhof PC
    Skin Pharmacol; 1990; 3(1):45-8. PubMed ID: 2167697
    [No Abstract]   [Full Text] [Related]  

  • 36. PUVA and UVB inhibit the intra-epidermal accumulation of polymorphonuclear leukocytes.
    Chang A; Alkemade JA; van de Kerkhof PC
    Br J Dermatol; 1988 Sep; 119(3):281-7. PubMed ID: 2846029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies of leukotriene B4-specific binding and function in rat polymorphonuclear leukocytes: absence of a chemotactic response.
    Kreisle RA; Parker CW; Griffin GL; Senior RM; Stenson WF
    J Immunol; 1985 May; 134(5):3356-63. PubMed ID: 2984287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphonuclear leukocytes cap a derivative of wheat germ agglutinin upon stimulation with formyl peptide and C5a but not leukotriene B4.
    Kurrasch R; Elfman F; Perez HD
    J Immunol; 1989 Sep; 143(6):1969-73. PubMed ID: 2550548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formation of free radicals and protein mixed disulfides in rat red cells exposed to dapsone hydroxylamine.
    Bradshaw TP; McMillan DC; Crouch RK; Jollow DJ
    Free Radic Biol Med; 1997; 22(7):1183-93. PubMed ID: 9098092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of leukotriene B5 on the accumulation of polymorphonuclear leukocytes (PMN) in normal skin and LTB4-stimulated human skin.
    Wozel G; Chang A; Barth J; Happle R; van de Kerkhof PC
    Agents Actions; 1991 Jan; 32(1-2):75-6. PubMed ID: 1647650
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.